Basking Ridge, NJ, United States of America

Anjali Agrawal

USPTO Granted Patents = 3 


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anjali Agrawal: Innovator in Pharmaceutical Compositions

Introduction

Anjali Agrawal is a prominent inventor based in Basking Ridge, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and methods. With a total of 3 patents to her name, her work is recognized for its potential impact on medical treatments.

Latest Patents

Anjali Agrawal's latest patents focus on pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile. These patents detail oral dosage formulations that include this compound, or its enantiomers, mixtures, tautomers, isotopologs, or pharmaceutically acceptable salts, along with a carrier or diluent. The patents also describe methods of preparing and using these pharmaceutical compositions, showcasing her innovative approach to drug formulation.

Career Highlights

Anjali Agrawal is currently employed at Celgene Corporation, where she continues to advance her research in pharmaceutical sciences. Her work at Celgene has positioned her as a key player in the development of new therapeutic solutions.

Collaborations

Anjali has collaborated with notable colleagues, including Ming J Chen and Shyam Babu Karki. These partnerships have contributed to her success and the advancement of her research initiatives.

Conclusion

Anjali Agrawal's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her patents and ongoing work at Celgene Corporation reflect her commitment to improving healthcare through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…